Enza Lonardo Stem Cells & Cancer Group, Molecular Pathology Program Spanish National Cancer Research Center Biography Publications Institution JoVE Articles Enza Lonardo has not added a biography. If you are Enza Lonardo and would like to personalize this page please email our Author Liaison for assistance. Publications The MiR-17-92 Cluster Counteracts Quiescence and Chemoresistance in a Distinct Subpopulation of Pancreatic Cancer Stem Cells Gut. Apr, 2015 | Pubmed ID: 25887381 Stromal Gene Expression Defines Poor-prognosis Subtypes in Colorectal Cancer Nature Genetics. Apr, 2015 | Pubmed ID: 25706628 Intracellular Autofluorescence: a Biomarker for Epithelial Cancer Stem Cells Nature Methods. Nov, 2014 | Pubmed ID: 25262208 Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells PloS One. 2013 | Pubmed ID: 24204632 Cripto Regulates Skeletal Muscle Regeneration and Modulates Satellite Cell Determination by Antagonizing Myostatin Proceedings of the National Academy of Sciences of the United States of America. Nov, 2012 | Pubmed ID: 23129614 Pancreatic Stellate Cells Form a Niche for Cancer Stem Cells and Promote Their Self-renewal and Invasiveness Cell Cycle (Georgetown, Tex.). Apr, 2012 | Pubmed ID: 22421149 Nodal/Activin Signaling Drives Self-renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy Cell Stem Cell. Nov, 2011 | Pubmed ID: 22056140 Pancreatic Cancer Stem Cells: New Insights and Perspectives Journal of Gastroenterology. Aug, 2011 | Pubmed ID: 21698355 A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation, and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease Stem Cells (Dayton, Ohio). Aug, 2010 | Pubmed ID: 20641036 Pancreatic Cancer Stem Cells - Update and Future Perspectives Molecular Oncology. Oct, 2010 | Pubmed ID: 20580623 Lack of Sik1 in Mouse Embryonic Stem Cells Impairs Cardiomyogenesis by Down-regulating the Cyclin-dependent Kinase Inhibitor P57kip2 PloS One. 2010 | Pubmed ID: 20140255 Cripto-1 is Required for Hypoxia to Induce Cardiac Differentiation of Mouse Embryonic Stem Cells The American Journal of Pathology. Nov, 2009 | Pubmed ID: 19834060 G Protein-coupled Receptor APJ and Its Ligand Apelin Act Downstream of Cripto to Specify Embryonic Stem Cells Toward the Cardiac Lineage Through Extracellular Signal-regulated Kinase/p70S6 Kinase Signaling Pathway Circulation Research. Jul, 2009 | Pubmed ID: 19574549 Effects of Indole-3-acetic Acid on Sinorhizobium Meliloti Survival and on Symbiotic Nitrogen Fixation and Stem Dry Weight Production Applied Microbiology and Biotechnology. Jun, 2009 | Pubmed ID: 19343341 Qualitative and Quantitative Proteomic Profiling of Cripto(-/-) Embryonic Stem Cells by Means of Accurate Mass LC-MS Analysis Journal of Proteome Research. Feb, 2009 | Pubmed ID: 19152270 Introduction of a Novel Pathway for IAA Biosynthesis to Rhizobia Alters Vetch Root Nodule Development Archives of Microbiology. Jul, 2008 | Pubmed ID: 18415080 Cripto Promotes A-P Axis Specification Independently of Its Stimulatory Effect on Nodal Autoinduction The Journal of Cell Biology. Feb, 2008 | Pubmed ID: 18268105 Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies Enza Lonardo1,2, Michele Cioffi1, Patricia Sancho1,3, Shanthini Crusz3, Christopher Heeschen1,3 1Stem Cells & Cancer Group, Molecular Pathology Program, Spanish National Cancer Research Center, 2Institute for Research in Biomedicine (IRB Barcelona), 3Center for Stem Cells in Cancer & Ageing, Barts Cancer Institute, Queen Mary University of London JoVE 52801 Medicine
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies Enza Lonardo1,2, Michele Cioffi1, Patricia Sancho1,3, Shanthini Crusz3, Christopher Heeschen1,3 1Stem Cells & Cancer Group, Molecular Pathology Program, Spanish National Cancer Research Center, 2Institute for Research in Biomedicine (IRB Barcelona), 3Center for Stem Cells in Cancer & Ageing, Barts Cancer Institute, Queen Mary University of London JoVE 52801 Medicine
